In the Replication genotyping phase with more case-control sets and in the meta- and pooled analyses, DEFA6, DEFB1, and INSL3 were still significantly associated with gastric cancer risk without heterogeneity across the phases. This evidence concerns the gene INSL3 and gastric cancer.